Publications by authors named "Ariel Nakache"
Background: Radial access is the default approach in interventional cardiology. The Axiostat® surgical hemostatic dressing, using chitosan as its active component, has demonstrated potential in accelerating blood clotting. This study aims to assess the efficacy and the safety of the Axiostat® dressing in achieving hemostasis in patients undergoing transradial coronary angioplasty (TRCA).
View Article and Find Full Text PDFBackground: The use of trans-catheter treatment for tricuspid regurgitation (TR) is currently increasing, especially trans-catheter edge-to-edge repair (TEER). However, patients with very large coaptation gaps are usually considered not eligible for this treatment.
Case Summary: We present the case of an 87-year-old man with symptomatic [New York Heart Association (NYHA) functional Class IV, right-sided heart failure signs] isolated torrential TR due to chronic atrial fibrillation who was initially considered not eligible for a tricuspid valve (TV) TEER because of a very large coaptation gap.
Article Synopsis
- STEMI patients with multivessel disease (MVD) generally have a worse prognosis, but recent studies suggest this gap might have narrowed with improved treatment.
- The study analyzed 1,886 STEMI patients who received timely primary PCI to compare outcomes based on the number of diseased vessels (one-, two-, and three-vessel disease).
- Results indicated that at one year, the rates of major adverse cardiovascular events (MACE) were similar across different vessel disease groups, suggesting that the prognosis for MVD patients may not be as poor as previously thought in modern medical settings.